These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 32191548)
1. An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations. Cozzolino M; Ketteler M; Wagner CA Expert Opin Ther Targets; 2020 May; 24(5):477-488. PubMed ID: 32191548 [No Abstract] [Full Text] [Related]
2. Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease. Fouque D; Vervloet M; Ketteler M Drugs; 2018 Aug; 78(12):1171-1186. PubMed ID: 30022383 [TBL] [Abstract][Full Text] [Related]
3. Small Intestinal Phosphate Absorption: Novel Therapeutic Implications. Yee J; Rosenbaum D; Jacobs JW; Sprague SM Am J Nephrol; 2021; 52(7):522-530. PubMed ID: 34515051 [TBL] [Abstract][Full Text] [Related]
4. Treating hyperphosphatemia - current and advancing drugs. Ketteler M; Liangos O; Biggar PH Expert Opin Pharmacother; 2016 Oct; 17(14):1873-9. PubMed ID: 27643443 [TBL] [Abstract][Full Text] [Related]
5. Contemporary management of phosphorus retention in chronic kidney disease: a review. Amiri FS Clin Exp Nephrol; 2015 Dec; 19(6):985-99. PubMed ID: 26032778 [TBL] [Abstract][Full Text] [Related]
6. Current and potential treatment options for hyperphosphatemia. Carfagna F; Del Vecchio L; Pontoriero G; Locatelli F Expert Opin Drug Saf; 2018 Jun; 17(6):597-607. PubMed ID: 29783873 [TBL] [Abstract][Full Text] [Related]
7. State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective. Scialla JJ; Kendrick J; Uribarri J; Kovesdy CP; Gutiérrez OM; Jimenez EY; Kramer HJ Am J Kidney Dis; 2021 Jan; 77(1):132-141. PubMed ID: 32771650 [TBL] [Abstract][Full Text] [Related]
8. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles. Locatelli F; Del Vecchio L; Violo L; Pontoriero G Expert Opin Drug Saf; 2014 May; 13(5):551-61. PubMed ID: 24702470 [TBL] [Abstract][Full Text] [Related]
9. Use of phosphate binders in chronic kidney disease. Ketteler M; Biggar PH Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841 [TBL] [Abstract][Full Text] [Related]
10. [Strategies aiming to control hyperphosphatemia in chronic kidney disease]. Ureña Torres PA Nephrol Ther; 2017 Apr; 13 Suppl 1():S95-S101. PubMed ID: 28577750 [TBL] [Abstract][Full Text] [Related]
12. Optimal use of phosphate binders in chronic kidney disease. Sonikian M; Papachristou E; Goumenos DS Expert Opin Pharmacother; 2013 Dec; 14(18):2521-32. PubMed ID: 24215605 [TBL] [Abstract][Full Text] [Related]
13. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Martin KJ; González EA Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848 [TBL] [Abstract][Full Text] [Related]
14. [Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction]. Negi S; Yamanaka S; Koreeda D; Yashiro M; Shigematsu T Clin Calcium; 2012 Oct; 22(10):1557-66. PubMed ID: 23023637 [TBL] [Abstract][Full Text] [Related]
15. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Patel L; Bernard LM; Elder GJ Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024 [TBL] [Abstract][Full Text] [Related]
17. Advances in pharmacotherapy for hyperphosphatemia in renal disease. Spasovski G Expert Opin Pharmacother; 2015; 16(17):2589-99. PubMed ID: 26374200 [TBL] [Abstract][Full Text] [Related]
18. Use of nicotinamide to treat hyperphosphatemia in dialysis patients. Lenglet A; Liabeuf S; Guffroy P; Fournier A; Brazier M; Massy ZA Drugs R D; 2013 Sep; 13(3):165-73. PubMed ID: 24000048 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. King AJ; Siegel M; He Y; Nie B; Wang J; Koo-McCoy S; Minassian NA; Jafri Q; Pan D; Kohler J; Kumaraswamy P; Kozuka K; Lewis JG; Dragoli D; Rosenbaum DP; O'Neill D; Plain A; Greasley PJ; Jönsson-Rylander AC; Karlsson D; Behrendt M; Strömstedt M; Ryden-Bergsten T; Knöpfel T; Pastor Arroyo EM; Hernando N; Marks J; Donowitz M; Wagner CA; Alexander RT; Caldwell JS Sci Transl Med; 2018 Aug; 10(456):. PubMed ID: 30158152 [TBL] [Abstract][Full Text] [Related]